TY - JOUR AU - Go, A. S. AU - Mozaffarian, D. AU - Roger, V. L. PY - 2014 DA - 2014// TI - Heart disease and stroke statistics--2014 update: a report from the American Heart Association JO - Circulation VL - 129 UR - https://doi.org/10.1161/01.cir.0000442015.53336.12 DO - 10.1161/01.cir.0000442015.53336.12 ID - Go2014 ER - TY - JOUR PY - 2004 DA - 2004// TI - Dyslipidemia management in adults with diabetes JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.2007.S68 DO - 10.2337/diacare.27.2007.S68 ID - ref2 ER - TY - JOUR AU - Manzato, E. AU - Zambon, A. AU - Lapolla, A. PY - 1993 DA - 1993// TI - Lipoprotein abnormalities in well-treated type II diabetic patients JO - Diabetes Care VL - 16 UR - https://doi.org/10.2337/diacare.16.2.469 DO - 10.2337/diacare.16.2.469 ID - Manzato1993 ER - TY - STD TI - Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106: 3143-21. ID - ref4 ER - TY - JOUR AU - Brunzell, J. D. AU - Davidson, M. AU - Furberg, C. D. PY - 2008 DA - 2008// TI - Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc08-9018 DO - 10.2337/dc08-9018 ID - Brunzell2008 ER - TY - JOUR AU - Davidson, M. H. AU - Ballantyne, C. M. AU - Jacobson, T. A. PY - 2011 DA - 2011// TI - Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists JO - J Clin Lipidol VL - 5 UR - https://doi.org/10.1016/j.jacl.2011.07.005 DO - 10.1016/j.jacl.2011.07.005 ID - Davidson2011 ER - TY - JOUR AU - Genest, J. AU - McPherson, R. AU - Frohlich, J. PY - 2009 DA - 2009// TI - 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations JO - Can J Cardiol VL - 25 UR - https://doi.org/10.1016/S0828-282X(09)70715-9 DO - 10.1016/S0828-282X(09)70715-9 ID - Genest2009 ER - TY - JOUR AU - Catapano, A. L. AU - Reiner, Ž. AU - Backer, G. PY - 2011 DA - 2011// TI - ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) JO - Atherosclerosis VL - 217 ID - Catapano2011 ER - TY - JOUR AU - Stone, N. J. AU - Robinson, J. AU - Lichtenstein, A. H. PY - 2014 DA - 2014// TI - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines JO - J Am Coll Cardiol VL - 65 UR - https://doi.org/10.1016/j.jacc.2013.11.002 DO - 10.1016/j.jacc.2013.11.002 ID - Stone2014 ER - TY - STD TI - Endocrinology Group Rejects New AHA/ACC CVD Guidelines. Medscape. Dec 13, 2013. ID - ref10 ER - TY - STD TI - NLA Statement on the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Available at: https://www.lipid.org/nla/2013-accaha-guideline-treatment-blood-cholesterol-reduce-atherosclerotic-cardiovascular-risk. Accessed 7 July 2016. UR - https://www.lipid.org/nla/2013-accaha-guideline-treatment-blood-cholesterol-reduce-atherosclerotic-cardiovascular-risk ID - ref11 ER - TY - JOUR PY - 2014 DA - 2014// TI - An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report JO - J Clin Lipidol VL - 8 UR - https://doi.org/10.1016/j.jacl.2013.12.005 DO - 10.1016/j.jacl.2013.12.005 ID - ref12 ER - TY - JOUR AU - Gibbons, G. H. AU - Shurin, S. B. AU - Mensah, G. A. AU - Lauer, M. S. PY - 2013 DA - 2013// TI - Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute JO - J Am Coll Cardiol VL - 15 UR - https://doi.org/10.1016/j.jacc.2013.08.003 DO - 10.1016/j.jacc.2013.08.003 ID - Gibbons2013 ER - TY - JOUR AU - Boekholdt, S. M. AU - Arsenault, B. J. AU - Mora, S. PY - 2012 DA - 2012// TI - Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis JO - JAMA VL - 307 UR - https://doi.org/10.1001/jama.2012.366 DO - 10.1001/jama.2012.366 ID - Boekholdt2012 ER - TY - JOUR AU - Ingelsson, E. AU - Schaefer, E. J. AU - Contois, J. H. PY - 2007 DA - 2007// TI - Clinical utility of different lipid measures for prediction of coronary heart disease in men and women JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.7.776 DO - 10.1001/jama.298.7.776 ID - Ingelsson2007 ER - TY - JOUR AU - Liu, J. AU - Sempos, C. T. AU - Donahue, R. P. AU - Dorn, J. AU - Trevisan, M. AU - Grundy, S. M. PY - 2006 DA - 2006// TI - Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease JO - Am J Cardiol VL - 98 UR - https://doi.org/10.1016/j.amjcard.2006.06.032 DO - 10.1016/j.amjcard.2006.06.032 ID - Liu2006 ER - TY - JOUR AU - Pischon, T. AU - Girman, C. J. AU - Sacks, F. M. AU - Rifai, N. AU - Stampfer, M. J. AU - Rimm, E. B. PY - 2005 DA - 2005// TI - Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men JO - Circulation VL - 112 UR - https://doi.org/10.1161/CIRCULATIONAHA.104.532499 DO - 10.1161/CIRCULATIONAHA.104.532499 ID - Pischon2005 ER - TY - JOUR AU - Robinson, J. G. AU - Wang, S. AU - Smith, B. J. AU - Jacobson, T. A. PY - 2009 DA - 2009// TI - Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk JO - J Am Coll Cardiol VL - 53 UR - https://doi.org/10.1016/j.jacc.2008.10.024 DO - 10.1016/j.jacc.2008.10.024 ID - Robinson2009 ER - TY - JOUR AU - Sniderman, A. D. AU - Williams, K. AU - Contois, J. H. PY - 2011 DA - 2011// TI - A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk JO - Circ Cardiovasc Qual Outcomes VL - 4 UR - https://doi.org/10.1161/CIRCOUTCOMES.110.959247 DO - 10.1161/CIRCOUTCOMES.110.959247 ID - Sniderman2011 ER - TY - JOUR AU - Davidson, M. H. PY - 2005 DA - 2005// TI - Reducing residual risk for patients on statin therapy: the potential role of combination therapy JO - Am J Cardiol VL - 96 UR - https://doi.org/10.1016/j.amjcard.2005.08.002 DO - 10.1016/j.amjcard.2005.08.002 ID - Davidson2005 ER - TY - JOUR AU - Guyton, J. R. AU - Goldberg, A. C. AU - Kreisberg, R. A. AU - Sprecher, D. L. AU - Superko, R. AU - O’Connor, C. M. PY - 1998 DA - 1998// TI - Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia JO - Am J Cardiol VL - 82 UR - https://doi.org/10.1016/S0002-9149(98)00448-2 DO - 10.1016/S0002-9149(98)00448-2 ID - Guyton1998 ER - TY - JOUR PY - 1975 DA - 1975// TI - Clofibrate and niacin in coronary heart disease JO - JAMA VL - 231 UR - https://doi.org/10.1001/jama.1975.03240160024021 DO - 10.1001/jama.1975.03240160024021 ID - ref22 ER - TY - JOUR AU - Brown, B. G. AU - Zhao, X. -. Q. AU - Chait, A. PY - 2001 DA - 2001// TI - Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011090 DO - 10.1056/NEJMoa011090 ID - Brown2001 ER - TY - JOUR AU - Taylor, A. J. AU - Sullenberger, L. E. AU - Lee, H. J. AU - Lee, J. K. AU - Grace, K. A. PY - 2004 DA - 2004// TI - Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2. A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000148955.19792.8D DO - 10.1161/01.CIR.0000148955.19792.8D ID - Taylor2004 ER - TY - JOUR PY - 2011 DA - 2011// TI - Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1107579 DO - 10.1056/NEJMoa1107579 ID - ref25 ER - TY - JOUR PY - 2014 DA - 2014// TI - Effects of extended-release niacin with laropiprant in high-risk patients JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1300955 DO - 10.1056/NEJMoa1300955 ID - ref26 ER - TY - JOUR AU - Guyton, J. R. AU - Slee, A. E. AU - Anderson, T. PY - 2013 DA - 2013// TI - Relationship of Lipoproteins to Cardiovascular Events: The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes) JO - J Am Coll Cardiol VL - 62 UR - https://doi.org/10.1016/j.jacc.2013.07.023 DO - 10.1016/j.jacc.2013.07.023 ID - Guyton2013 ER - TY - JOUR AU - Ballantyne, C. M. AU - Andrews, T. C. AU - Hsia, J. A. AU - Kramer, J. H. AU - Shear, C. PY - 2001 DA - 2001// TI - Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels JO - Am J Cardiol VL - 88 UR - https://doi.org/10.1016/S0002-9149(01)01638-1 DO - 10.1016/S0002-9149(01)01638-1 ID - Ballantyne2001 ER - TY - JOUR AU - Ballantyne, C. M. AU - Raichlen, J. S. AU - Cain, V. A. PY - 2008 DA - 2008// TI - Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial JO - J Am Coll Cardiol VL - 52 UR - https://doi.org/10.1016/j.jacc.2008.04.052 DO - 10.1016/j.jacc.2008.04.052 ID - Ballantyne2008 ER - TY - JOUR AU - Charlton-Menys, V. AU - Betteridge, D. J. AU - Colhoun, H. PY - 2009 DA - 2009// TI - Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2008.111401 DO - 10.1373/clinchem.2008.111401 ID - Charlton-Menys2009 ER - TY - JOUR AU - Idris, I. AU - Tate, H. AU - Ahmad, A. AU - McCormack, T. PY - 2011 DA - 2011// TI - Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study JO - J Clin Lipidol VL - 5 UR - https://doi.org/10.1016/j.jacl.2011.06.001 DO - 10.1016/j.jacl.2011.06.001 ID - Idris2011 ER - TY - JOUR AU - Grundy, S. M. AU - Vega, G. L. AU - Tomassini, J. E. AU - Tershakovec, A. M. PY - 2009 DA - 2009// TI - Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial) JO - Am J Cardiol VL - 104 UR - https://doi.org/10.1016/j.amjcard.2009.04.018 DO - 10.1016/j.amjcard.2009.04.018 ID - Grundy2009 ER - TY - JOUR AU - Farnier, M. AU - Taggart, W. AU - Dong, Q. AU - Lin, J. AU - Shah, A. AU - Brudi, P. PY - 2011 DA - 2011// TI - Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of LDL and non-HDL cholesterol with apolipoprotein B in mixed dyslipidemic patients JO - J Clin Lipidol VL - 5 UR - https://doi.org/10.1016/j.jacl.2011.02.009 DO - 10.1016/j.jacl.2011.02.009 ID - Farnier2011 ER - TY - JOUR AU - Farnier, M. AU - Guyton, J. R. AU - Jensen, E. AU - Polis, A. B. AU - Johnson-Levonas, A. O. AU - Brudi, P. PY - 2013 DA - 2013// TI - Effects of Ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non HDL cholesterol in patients with primary hypercholesterolemia JO - Atherosclerosis VL - 229 UR - https://doi.org/10.1016/j.atherosclerosis.2013.05.010 DO - 10.1016/j.atherosclerosis.2013.05.010 ID - Farnier2013 ER - TY - JOUR AU - Farnier, M. AU - Chen, E. AU - Johnson-Levonas, A. O. AU - McCrary Sisk, C. AU - Mitchel, Y. B. PY - 2014 DA - 2014// TI - Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia JO - Vasc Health Risk Manag VL - 10 UR - https://doi.org/10.2147/VHRM.S58694 DO - 10.2147/VHRM.S58694 ID - Farnier2014 ER - TY - JOUR AU - MacLean, A. AU - McKenney, J. M. AU - Scott, R. PY - 2011 DA - 2011// TI - Efficacy and safety of extended-release niacin/laropiprant in patients with type 2 diabetes mellitusBr JO - J Cardiol VL - 18 ID - MacLean2011 ER - TY - JOUR AU - Fridewald, W. T. AU - Levy, R. I. AU - Fredrickson, D. S. PY - 1972 DA - 1972// TI - Estimation of the concentration of low-density lipoprotein cholesterols in plasma, without use of the preparative ultracentrifuge JO - Clin Chem VL - 18 ID - Fridewald1972 ER - TY - JOUR AU - Maccubbin, D. AU - Bays, H. E. AU - Olsson, A. G. PY - 2008 DA - 2008// TI - Lipid-modifying efficacy and tolerability of extended release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia JO - Int J Clin Pract VL - 62 UR - https://doi.org/10.1111/j.1742-1241.2008.01938.x DO - 10.1111/j.1742-1241.2008.01938.x ID - Maccubbin2008 ER -